Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2005
04/14/2005US20050080117 Substituted benzoxazoles as estrogenic agents
04/14/2005US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
04/14/2005US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
04/14/2005US20050079381 Rubrene derivatives emit blue light; glass substrate supports a hole injecting layer, a hole transporting layer, and a light emitting layer
04/13/2005EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia
04/13/2005EP1073640B1 Naphthalene derivatives, their production and use
04/13/2005CN1196687C Inhibitors of IMPDH enzyme
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878739 Composition for treating or preventing glomerulopathy
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/12/2005CA2174107C Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
04/12/2005CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives
04/12/2005CA2122571C Adhesion receptor antagonists
04/07/2005WO2005030739A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
04/07/2005WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030700A2 Amino acids with affinity for the alpha2delta-protein
04/07/2005WO2005016898A3 Stable polymorph of bifeprunox mesilate
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075506 Process for preparing florfenicol
04/07/2005US20050075505 Reacting 3-(3,5-dimethylphenoxy)-2-hydroxypropylamine with such as ethyl chloroformate under alkaline conditions; high yield; reduced energy
04/07/2005US20050075382 Compounds as bactericides or drugs
04/07/2005US20050075381 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents
04/07/2005US20050075380 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases
04/07/2005US20050075323 Beta3 adrenergic receptor agonists and uses thereof
04/07/2005CA2540208A1 Amino acids with affinity for the alpha2delta-protein
04/07/2005CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/07/2005CA2537877A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
04/06/2005EP1520856A1 Androgen receptor agonist
04/06/2005EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy
04/06/2005EP1519925A1 Oxazole derivatives and their use as insulin sensitizers
04/06/2005EP1519924A1 Difluorothioacetamides of oxazolidinones as antibacterial agents
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1519722A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents
04/06/2005EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
04/06/2005EP1250299B1 Chiral ionic liquids
04/06/2005EP1135349B1 Process for preparing chiral compounds
04/06/2005CN1603315A Method for preparing oxazolidine
04/06/2005CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/06/2005CN1195753C Fused-benzene derivatives useful as herbicides
04/06/2005CN1195746C Preparation method of N-carboxy anhydride
04/06/2005CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
04/05/2005US6875874 Using thionyl chloride
04/05/2005US6875871 Oxazolidinone photoaffinity probes
04/05/2005US6875785 Nonsteroidal antiinflammatory agents, e.g., N-hydroxy-1-(4-sulfonyl or aminosulfonyl)phenyl)-(ring- substituted hetero-cyclyl)alkanamide or -urea; dual enzyme inhibitors with minimal side effects; asthma; antiallergens; antipyretics
04/05/2005US6875782 Antidiabetic agents, dietetics, anticancer agents
04/05/2005US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same
03/2005
03/31/2005WO2005028454A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/31/2005WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/31/2005WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
03/31/2005WO2005028413A1 Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same
03/31/2005WO2004108133A3 Modulators of vr1 receptor
03/31/2005WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/31/2005US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents
03/31/2005US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
03/31/2005US20050070532 Peroxisome proliferator activated receptors (PPARS); for inhibiting formation of adipocytes; for treatment of obesity, diabetes, hyperinsulinemia, and polycystic ovary syndrome
03/31/2005US20050070526 Novel antibacterial agents
03/31/2005CA2539554A1 Phenylacetic acid derivative, process for producing the same, and use
03/31/2005CA2539306A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/31/2005CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/30/2005EP1517974A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/30/2005EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
03/30/2005EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
03/30/2005EP1307182B1 Pharmaceutical composition for transdermal delivery of befloxatone
03/30/2005EP1237551B1 Pharmaceutical formulations containing zolmitriptan
03/30/2005EP0586385B2 Enantiomer separating process on chiral separation phases by means of a continuous counter-current chromatography process
03/30/2005CN1602341A 树脂组合物 Resin composition
03/30/2005CN1602290A Process for the synthesis of chirally pure beta -amino-alcohols
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect
03/30/2005CN1194960C Method for preparing 4,5-diamino shikimic acid derivative
03/24/2005WO2005026137A2 Modulators of atp-binding cassette transporters
03/24/2005WO2005026134A1 Organic compounds
03/24/2005WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2005005456A3 Peptide deformylase inhibitors
03/24/2005US20050065353 Mitosis agents; antitumor agents; anticancer agents
03/24/2005US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage
03/24/2005US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
03/24/2005US20050065198 Inhibitors of 15-lipoxygenase
03/24/2005US20050065187 Novel antimicrobial aryloxazolidinone compounds
03/24/2005CA2539016A1 Organic compounds
03/24/2005CA2537841A1 Modulators of atp-binding cassette transporters
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1515694A1 Benzoxazole and benzodiazole uv-a sunscreens
03/23/2005EP1419125A4 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
03/23/2005EP1347969B1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
03/23/2005CN1597672A Substituierte benzoylcyclohexandione
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 210